BSE filing, NSE: SMSPHARMA. Summary written from the filing by ALFA Finder's alert engine.
SMS Pharmaceuticals Ltd: key numbers
- Share price
- ₹485.80
- Market cap
- ₹4,307 Cr
- Revenue (annual)
- ₹886.9 Cr
- Net profit (annual)
- ₹102.0 Cr
- P/E (TTM)
- 42.0×Sector 48.7×
- Promoter holding
- 68.07%+0.00% QoQ
- FII holding
- 1.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SMS Pharmaceuticals Ltd
All →SMS Pharmaceuticals Board Meeting Date
SMS Pharmaceuticals has scheduled a board meeting for November 4, 2026, to consider Q2 FY27 unaudited results. This is a routine advance intimation.
SMS Pharmaceuticals Other Announcement
SMS Pharmaceuticals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.
SMS Pharmaceuticals Annual General Meeting
SMS Pharmaceuticals Limited held its 38th Annual General Meeting on September 29, 2026. Shareholders transacted business including the adoption of financial statements and declaration of dividend.
SMS Pharmaceuticals Other Announcement
SMS Pharmaceuticals disclosed two market sell trades by Designated Person NVV Satyanarayana totalling ₹0.14 Crore. The PIT Reg 7(2) intimation involves a non-promoter designated person.
- Value
- ₹0.14 Cr
SMS Pharmaceuticals Annual General Meeting
SMS Pharmaceuticals Limited has scheduled its 38th Annual General Meeting for September 29, 2026. Key agenda items include dividend declaration, management re-appointments, and approval of material related party transactions.
SMS Pharmaceuticals Annual Report
SMS Pharmaceuticals Limited has released its Annual Report and Notice for the 38th Annual General Meeting scheduled for September 29, 2026. The company reported FY26 revenue of ₹887 Crore.
Other debt & borrowing announcements
All →QGO Finance Debt & Borrowing: ₹1 Cr
QGO Finance Ltd has redeemed 100 unlisted non-convertible debentures, with a total value of Rs. 1 Crore, including the principal and applicable interest.
- Value
- ₹1.00 Cr
Capri Global Capital Debt & Borrowing: ₹1.42 Cr
Capri Global paid interest on four listed NCD series ahead of their due dates, totalling Rs.1.42 Crore. The Reg 57 certificate reports no payment changes or delays.
- Value
- ₹1.42 Cr
Ugro Capital Debt & Borrowing: ₹2.99 Cr
Ugro Capital paid Rs 2.99 Crore in interest on two NCD series on 29 October 2026. Payments were made a day before the 30 October due date.
- Value
- ₹2.99 Cr
Time Technoplast Debt & Borrowing: ₹50 Cr
Time Technoplast redeemed its Rs.50 Crore commercial paper in full on maturity on 29 October 2026. The redemption completes servicing of this short-term debt instrument.
- Value
- ₹50.00 Cr
Samvardhana Motherson International Debt & Borrowing: ₹834.8 Cr
Samvardhana Motherson issued a corporate guarantee for a EUR 75 million BNP Paribas term facility of subsidiary MGI B.V. Liability capped at ₹834.75 Crore.
- Value
- ₹834.8 Cr
- Execution
- Guarantee valid up to February 28, 2032
Electrotherm (India) Debt & Borrowing: ₹59.81 Cr
Electrotherm disclosed a Rs 59.81 Crore default on bank loans as at 30 September 2026. The loans were assigned to an ARC under a settlement.
- Value
- ₹59.81 Cr